Acta Derm Venereol

1. PEZZOLO E, Mariateresa R, Luyo Saboya RA, Malagoli P, et al
   Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis).
   Acta Derm Venereol. 2026;106:0193.
   

   >> Share

   
   

   
   Allergy

2. CZARNOWICKI T, Sugita K, Yiu Z, Diez-Ribas S, et al
   Divergent Paths: A Comprehensive Review of Mechanisms and Clinical Implications in Atopic Dermatitis and Psoriasis.
   Allergy. 2026 Apr 15. doi: 10.1111/all.70347.
   

   >> Share

   
   
3. HSIN L, Reinwald S, von Borstel A, Aui PM, et al
   Biphasic Effects on Allergen-Specific Type 2 Memory B Cells Over 18 Months Sublingual Immunotherapy for House Dust Mite Allergy.
   Allergy. 2026 Apr 17. doi: 10.1111/all.70342.
   

   >> Share

   
   
4. VELLAICHAMY MANIAN D, Butterfield JH, Meeusen JW, Mattke A, et al
   Urine Mast Cell Mediator Levels in the Pediatric Population with and without Allergic Disease Stratified by Age and Gender: A Novel Diagnostic Insight.
   Allergy. 2026 Apr 17. doi: 10.1111/all.70343.
   

   >> Share

   
   
5. GODSELL JD, Trubiano JA
   Adrenaline, Anaphylaxis, and Experimental Evidence.
   Allergy. 2026 Apr 18. doi: 10.1111/all.70354.
   

   >> Share

   
   

   
   Ann Allergy Asthma Immunol

6. MEADOWS JA, Gross GN, Forester JP, Sublett JW, et al
   Reaffirming the Scientific and Economic Foundations of Allergen Immunotherapy.
   Ann Allergy Asthma Immunol. 2026 Apr 10:S1081-1206(26)00153.
   

   >> Share

   
   
7. NGUYEN V, Bartnikas L, Bingemann T, Herbert LJ, et al
   Allergist impact on anxiety: Findings from a survey of caregivers of patients with food allergy.
   Ann Allergy Asthma Immunol. 2026 Apr 10:S1081-1206(26)00155.
   

   >> Share

   
   
8. HAINES A, Rosenstreich D, Hudes G, Ramesh M, et al
   Challenges with nasal challenges: diagnosing local allergic rhinitis in the Bronx population.
   Ann Allergy Asthma Immunol. 2026 Apr 11:S1081-1206(26)00151.
   

   >> Share

   
   

   
   Arerugi

9. YUTA A, Ogawa Y, Kozaki H, Matsumoto K, et al
   [POST-TREATMENT SURVEY OF THE MAINTENANCE OF EFFECTS FOR CEDAR SUBLINGUAL IMMUNOTHERAPY].
   Arerugi. 2026;75:132-141.
   

   >> Share

   
   
10. ONAGAWA Y, Kubota K, Horikawa Y, Goto A, et al
    [TYPICAL COLD URTICARIA EASILY TRIGGERED BY EXERCISE IN A 13-YEAR-OLD GIRL].
    Arerugi. 2026;75:142-146.
    

    >> Share

    
    
11. ITOGA M, Oyama S, Nunomura Y, Fukushima T, et al
    [DIAGNOSIS OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-NEGATIVE EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS BASED ON RENAL PATHOLOGICAL FINDINGS WITHOUT ASTHMA].
    Arerugi. 2026;75:147-152.
    

    >> Share

    
    
12. HARIGANE R, Rikimaru M, Kume H
    [A CASE OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS THAT DEVELOPED FROM DE NOVO SENSITIZATION IN A STABLE NON-ATOPIC ASTHMA, DIAGNOSED BY COMPUTED TOMOGRAPHY].
    Arerugi. 2026;75:153-158.
    

    >> Share

    
    
13. WAKAO H
    [UNCONVENTIONAL T CELLS IN ALLERGIC DISEASES].
    Arerugi. 2026;75:84-90.
    

    >> Share

    
    
14. WASHIO K
    [ALLERGIC CONTACT DERMATITIS AND SYSTEMIC CONTACT DERMATITIS DUE TO METAL ALLERGENS].
    Arerugi. 2026;75:91-97.
    

    >> Share

    
    

    
    Br J Dermatol

15. KHOSHNIYATI S, Fleischli A, Niknejad K, Weiner J, et al
    The prognostic impact of prior atopic dermatitis on cutaneous T-cell lymphoma: a single-center retrospective cohort study.
    Br J Dermatol. 2026 Apr 16:ljag143. doi: 10.1093.
    

    >> Share

    
    
16. SILVERBERG JI, Dodiuk-Gad R, Takaoka R, Tan J, et al
    More than a symptom: itch as an independent clinical contributor in atopic dermatitis - a global-scale study on 15,223 patients.
    Br J Dermatol. 2026 Apr 11:ljag142. doi: 10.1093.
    

    >> Share

    
    
17. BRODERICK C, Poulsen CS, Hjelmso MH, Marrs T, et al
    Associations between early-life exposures and the infant skin microbiome.
    Br J Dermatol. 2026 Jan 16:ljaf524. doi: 10.1093.
    

    >> Share

    
    

    
    Chest

18. CHAO WC, Liao SY
    Comparative Outcomes and Side Effects of Immunosuppressants and Tumor Necrosis Factor Inhibitors in Sarcoidosis: A Real-World Data Analysis.
    Chest. 2026;169:1006-1017.
    

    >> Share

    
    
19. CELIS-PRECIADO CA, Hamou Kuijpers EB, Ramakrishnan S, Howell I, et al
    Applying precision medicine to the heterogeneity of asthma attacks.
    Chest. 2025 Nov 13:S0012-3692(25)05695-8. doi: 10.1016/j.chest.2025.
    

    >> Share

    
    
20. PEIRCE AM, Hogan CK, Weinstein JB, Seelye SM, et al
    Clinician Views on Inhaler Substitution in the Veterans Health Administration.
    Chest. 2026;169:1039-1050.
    

    >> Share

    
    
21. TAILLE C, Hamidi F, Heddebaut N, Pote N, et al
    Impact of mepolizumab on airway remodeling and inflammation in severe eosinophilic asthma.
    Chest. 2025 Dec 5:S0012-3692(25)05814-3. doi: 10.1016/j.chest.2025.
    

    >> Share

    
    
22. WU Z, Yazbeck L, Smith DJF, Holt K, et al
    Characterising cough and its response to therapy in hypersensitivity pneumonitis.
    Chest. 2026 Apr 8:S0012-3692(26)00439-3. doi: 10.1016/j.chest.2026.
    

    >> Share

    
    

    
    Contact Dermatitis

23. UTER W, Funch AB, Jensen MB, Larsen CK, et al
    Solid Shampoo Is Mostly Not Preserved, in Contrast to Liquid Shampoos Used in Hairdressing-A Market Survey in Four European Countries.
    Contact Dermatitis. 2026;94:524-530.
    

    >> Share

    
    
24. DE GROOT AC, Ipenburg NA, Rustemeyer T
    Co-Reactivity of Fragrances and Fragrance-Markers in Patients With Positive Patch Tests to Chinese and Brazilian Propolis.
    Contact Dermatitis. 2026;94:482-487.
    

    >> Share

    
    
25. HASEN A, Yao M, Li T, Jiang Y, et al
    Cosmetic Adverse Reactions and Prognostic Factors: A Retrospective Cohort Study in Wuhan, China.
    Contact Dermatitis. 2026;94:475-481.
    

    >> Share

    
    
26. BOTVID S, Sogaard R, Schwensen JFB, Johansen JD, et al
    Ten Years of Patch Testing to Hydroperoxides of Limonene and Linalool: Prevalence, Patterns and Clinical Insights.
    Contact Dermatitis. 2026;94:504-514.
    

    >> Share

    
    
27. WOLFF ELG, Svendsen SV, Houlberg MNA, Norreslet LB, et al
    The Value of Patch Testing With Stoma Care Products Among Patients With an Ostomy.
    Contact Dermatitis. 2026;94:531-537.
    

    >> Share

    
    
28. KARELS S, Weber B, Hylwa S, Ophaug S, et al
    To Avoid or Not to Avoid: Cross-Reactivity Between Fragrance and Common Botanicals.
    Contact Dermatitis. 2026;94:488-493.
    

    >> Share

    
    
29. JONKER JAG, Tamminga SJ, Los FS, Janse PMV, et al
    Interventions and Implementation Strategies for Preventing Occupational Contact Dermatitis: A Scoping Review.
    Contact Dermatitis. 2026;94:437-464.
    

    >> Share

    
    
30. OZKAYA E, Aydogan YY, Erdem Y
    Old But Not Gone: Nitrofurazone-Induced Occupational Allergic Contact Dermatitis in a Racehorse Groom.
    Contact Dermatitis. 2026 Apr 10. doi: 10.1111/cod.70155.
    

    >> Share

    
    
31. LEVIN EJ, Chung C, Hermes K, Lim HW, et al
    Allergen Content of Inactive Ingredients in Best-Selling Sunscreens: A Comparison of Key Product Features.
    Contact Dermatitis. 2026 Apr 12. doi: 10.1111/cod.70141.
    

    >> Share

    
    

    
    Int Arch Allergy Immunol

32. HE L, Li X, Wang Y, Wang Q, et al
    Bioinformatics Analysis and Animal Experiments Revealed the Potential Role of IGFBP3 in Allergic Rhinitis.
    Int Arch Allergy Immunol. 2026 Apr 10:1-18. doi: 10.1159/000551921.
    

    >> Share

    
    

    
    J Allergy Clin Immunol

33. CALVAO J, de Masson A, Cozzio A, Assaf C, et al
    Dupilumab therapy in atopic dermatitis when cutaneous lymphoma is suspected: Consensus recommendations from the EORTC Cutaneous Lymphoma Tumour Group.
    J Allergy Clin Immunol. 2026 Apr 10:S0091-6749(26)00254.
    

    >> Share

    
    

    
    J Am Acad Dermatol

34. SHAH MM, Mohammad AP, Ko JM, Bae GH, et al
    EPIC Cosmos Analysis of Dupilumab Utilization and Access Disparities in Atopic Dermatitis.
    J Am Acad Dermatol. 2026 Apr 9:S0190-9622(26)00539.
    

    >> Share

    
    

    
    J Asthma

35. BOZEK A, Miodonska M, Sadowska D, Zalejska Fijolka J, et al
    Three years treatment with HDM allergen immunotherapy, omalizumab, or combination therapy in allergic asthma: clinical outcomes and biomarkers.
    J Asthma. 2026 Apr 15:1-18. doi: 10.1080/02770903.2026.2660096.
    

    >> Share

    
    

    
    J Dermatol

36. AOKI A, Fukamatsu H, Yamamoto T, Aoyama Y, et al
    Sunflower Seed-Induced Anaphylaxis With Immunoglobulin E Reactivity to 2S Albumins and Novel 60 kDa Antigen Identified by Immunoblot Analysis.
    J Dermatol. 2026 Apr 10. doi: 10.1111/1346-8138.70266.
    

    >> Share

    
    

    
    J Immunol

37. SUI S, Yang L, Ji D, Guo J, et al
    miR-449b-5p from adipose-derived mesenchymal stem cell-derived exosomes targets IGF1R to alleviate airway inflammation and improve airway smooth muscle cell dysfunction in children with asthma.
    J Immunol. 2026;215:vkaf376.
    

    >> Share

    
    

    
    Pediatrics

38. WITT BS, Wright BL
    A Collaborative Initiative to Improve Anaphylaxis Management in Utah Schools.
    Pediatrics. 2026 Apr 15:e2025073978. doi: 10.1542/peds.2025-073978.
    

    >> Share

    
    

    
    PLoS Comput Biol

39. ZHANG M, Kim YW, Yang CX, Gauvreau GM, et al
    Using cell-specific late-phase asthma mRNA biomarkers to repurpose drugs that concurrently reverse disease signatures across multiple immune cell-types.
    PLoS Comput Biol. 2026;22:e1014081.
    

    >> Share

    
    

    
    PLoS One

40. LIU L, Sun Y, Wang Y, Xie X, et al
    Bioinformatics analysis and qRT-PCR validation of iron metabolism-related genes in pediatric asthma.
    PLoS One. 2026;21:e0346063.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share